Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation. (4th November 2015) - Hou, Yafei; Kohanbash, Gary; Okada, Kaori; Shrivastav, Shruti; Smith-Cohn, Matthew; Nicolaides, Theodore; Mueller, Sabine; Carcaboso, Angel; Pollack, Ian; Okada, Hideho